Revvity Inc.
$ 99.66
-1.83%
12 Jun - close price
- Market Cap 11,325,549,000 USD
- Current Price $ 99.66
- High / Low $ 103.60 / 98.42
- Stock P/E 48.81
- Book Value 64.34
- EPS 2.08
- Next Earning Report 2026-07-27
- Dividend Per Share $0.28
- Dividend Yield 0.28 %
- Next Dividend Date 2026-08-07
- ROA 0.02 %
- ROE 0.03 %
- 52 Week High 118.21
- 52 Week Low 81.19
About
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham, Massachusetts.
Analyst Target Price
$113.64
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-02 | 2025-10-27 | 2025-07-28 | 2025-04-28 | 2025-01-31 | 2024-11-04 | 2024-07-29 | 2024-04-29 | 2024-02-01 | 2023-10-30 | 2023-08-01 |
| Reported EPS | 1.06 | 0.87 | 0.4 | 1.18 | 1.01 | 1.42 | 1.28 | 1.22 | 0.98 | 1.25 | 1.18 | 1.21 |
| Estimated EPS | 1.01 | 0.85 | 0.5 | 1.14 | 0.95 | 1.38 | 1.13 | 1.12 | 0.94 | 1.16 | 1.19 | 1.19 |
| Surprise | 0.05 | 0.02 | -0.1 | 0.04 | 0.06 | 0.04 | 0.15 | 0.1 | 0.04 | 0.09 | -0.01 | 0.02 |
| Surprise Percentage | 4.9505% | 2.3529% | -20% | 3.5088% | 6.3158% | 2.8986% | 13.2743% | 8.9286% | 4.2553% | 7.7586% | -0.8403% | 1.6807% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-27 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 1.23 |
| Currency | USD |
Previous Dividend Records
| Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-08-07 | 2026-05-08 | 2026-02-06 | 2025-11-07 | 2025-08-08 | 2025-05-09 | 2025-02-07 | 2024-11-08 | 2024-08-09 | 2024-05-10 |
| Amount | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 |
Next Dividend Records
| Dividend per share (year): | $0.28 |
| Dividend Yield | 0.28% |
| Next Dividend Date | 2026-08-07 |
| Ex-Dividend Date | 2026-07-17 |
Recent News: RVTY
2026-06-12 10:38:26
Revvity's Opera Phenix Plus high-content screening system is a key imaging platform for drug discovery and cell biology, offering fast, confocal imaging and multiplexed assay capabilities. It is designed for high-throughput screening in 96, 384, and 1,536-well plate formats, supporting both fixed and live-cell applications with advanced features like water-immersion objectives and integrated automation. The system targets pharma, biotech, academic, and core facilities in the US that require superior throughput and image quality for complex phenotypic assays.
2026-06-12 07:26:30
Revvity Inc. (US76155R1086) experienced a neutral trading day with no significant news or catalysts impacting the stock. Despite being a focus for US retail investors, there were no new earnings reports, analyst rating changes, or major price movements. The article suggests that investors should consider the company's structural business model within the life sciences tools and diagnostics industry rather than anticipating short-term news-driven moves.
2026-06-10 17:15:00
Revvity Inc. (RVTY) stock fell by 2.73% on Wednesday, closing at $101.29, despite a two-day winning streak. This underperformance occurred on an overall negative trading day where the S&P 500 Index and Dow Jones Industrial Average also experienced significant declines.
2026-06-09 20:43:26
Revvity is strategically repositioning itself as a diagnostics and life science tools provider, emphasizing instruments, consumables, and software to support research and clinical workflows. Investors are closely watching how this transformation impacts revenue growth and margins, especially given the company's competitive stance in the US healthcare market. The stock offers exposure to structural growth drivers in diagnostics and scientific R&D, with long-term success dependent on execution, innovation, and the broader funding environment.
2026-06-09 18:18:59
Revvity Inc (RVTY) shares surged 3.8% to $104.13, displaying a positive price performance over the past year. GuruFocus's GF Value™ indicates the stock is currently undervalued by 13.5%, despite its P/E (TTM) being significantly higher than its 5-year median. The company holds a GF Score™ of 78/100, suggesting favorable overall financial health, but a low growth rank and absence of insider buying activity warrant investor caution.
